Reconstruction options and outcomes for breast sarcoma patients

Hannah M. Carl, Nicholas A. Calotta, Charalampos Siotos, Tobias J. Bos, Dennis G. Foster, Michele Manahan, Carisa Miller Cooney, Justin Michael Sacks, Gedge David Rosson

Research output: Contribution to journalArticlepeer-review

Abstract

Breast sarcomas constitute a rare and heterogeneous group of tumors. Given their aggressive nature and the potential for extensive resections, rates of reconstruction have been low. We retrospectively reviewed subjects derived from our institutional registry presented between 2003 and 2015. Thirty-four patients with primary breast sarcoma were identified. The average age was 51.9 years and the average follow-up was 58 months. The most common histological type was malignant phyllodes (61.8%). Two patients suffered cancer recurrence. Twelve patients (35.3%) underwent reconstruction. Four underwent implant-based reconstruction, seven had autologous-based reconstruction, and one had combined reconstruction. Major complications were one flap loss and one implant removal. Our relatively high rates of breast reconstruction suggest a newly increased willingness to offer reconstruction to this rarer patient population.

Original languageEnglish (US)
JournalBreast Journal
DOIs
StatePublished - Jan 1 2019

Keywords

  • breast cancer
  • breast reconstruction
  • breast surgery
  • sarcoma

ASJC Scopus subject areas

  • Internal Medicine
  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Reconstruction options and outcomes for breast sarcoma patients'. Together they form a unique fingerprint.

Cite this